Skip to main content
Journal cover image

Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy.

Publication ,  Journal Article
Czito, BG; Willett, CG
Published in: Semin Radiat Oncol
July 2011

The management of rectal cancer has undergone significant evolution with advances in surgery, radiation therapy, and chemotherapy. These advances have translated into improved rates of local control, survival, and quality of life. More recently, the integration of newer chemotherapeutic and targeted agents in patients with advanced colorectal cancer have led to further improvements in disease-free and overall survival. These agents are now being studied with radiation therapy in the neoadjuvant therapy of rectal cancer.

Duke Scholars

Published In

Semin Radiat Oncol

DOI

EISSN

1532-9461

Publication Date

July 2011

Volume

21

Issue

3

Start / End Page

203 / 211

Location

United States

Related Subject Headings

  • Vascular Endothelial Growth Factor A
  • Survival Rate
  • Rectal Neoplasms
  • Radiotherapy, Adjuvant
  • Quality of Life
  • Oncology & Carcinogenesis
  • Neoplasm Recurrence, Local
  • Neoadjuvant Therapy
  • Humans
  • Fluorouracil
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Czito, B. G., & Willett, C. G. (2011). Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy. Semin Radiat Oncol, 21(3), 203–211. https://doi.org/10.1016/j.semradonc.2011.02.006
Czito, Brian G., and Christopher G. Willett. “Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy.Semin Radiat Oncol 21, no. 3 (July 2011): 203–11. https://doi.org/10.1016/j.semradonc.2011.02.006.
Czito, Brian G., and Christopher G. Willett. “Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy.Semin Radiat Oncol, vol. 21, no. 3, July 2011, pp. 203–11. Pubmed, doi:10.1016/j.semradonc.2011.02.006.
Journal cover image

Published In

Semin Radiat Oncol

DOI

EISSN

1532-9461

Publication Date

July 2011

Volume

21

Issue

3

Start / End Page

203 / 211

Location

United States

Related Subject Headings

  • Vascular Endothelial Growth Factor A
  • Survival Rate
  • Rectal Neoplasms
  • Radiotherapy, Adjuvant
  • Quality of Life
  • Oncology & Carcinogenesis
  • Neoplasm Recurrence, Local
  • Neoadjuvant Therapy
  • Humans
  • Fluorouracil